All In MedTech

Device Trial Radar · NCT07209852

Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up

Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up (SEPTA PMCF)

Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

141

Actual

Start

Dec 19, 2025

Primary completion

Aug 31, 2029

Study completion Aug 31, 2029

Sponsor

Lead sponsor
Boston Scientific CorporationPublic (BSX)
Sponsor type
Industry
First posted
Oct 7, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this observational post-market clinical Follow-up study is to learn about the long-term safety, performance, and clinical benefits of pacing the left bundle branch area (LBBAP) using the INGEVITY+ pacemaker lead in patients with bradycardia who need a pacemaker.

Conditions

  • Bradycardia
  • Atrioventricular Block
  • Sinus Node Dysfunction
  • Bundle-Branch Block

Interventions

  • Pacemaker leadDevice

    The pacemaker lead under investigation is a bipolar, steroid-releasing pacemaker electrode with active fixation (IS-1 connection) designed for chronic stimulation and sensing in the right atrium, right ventricle or left bundle branch area (LBBA). In this study, the lead is implanted in the LBBA and connected to a single- or dual-chamber pacemaker. Implantation is performed using a compatible, CE-marked catheter for pacemaker implantation.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. LBBA Implant Success RateTime frame: At the time of implant procedure (Day 0).
  2. Maintenance of Ventricular Synchrony (Paced QRS Duration)Time frame: From implant through 3-year follow-up.

Locations

13 sites in 7 countries. Site status is shown where the registry gives one.

  • St. Jan-Hospital

    Bruges, Belgium

  • Clinique Saint-Pierre Ottignies-Hospital

    Brussels, Belgium

  • CHRU de Lille

    Lille, France

10 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.